logo

For the Inventor, By the Inventor

Pune, India

Mukund Keshao Gurjar

This inventor holds 12 USPTO granted patents. Top assignees: Council of Scientific and Industrial Research, Millennium Pharmaceuticals Limited, Millenium Pharmaceuticals, Inc.. Active years: 2001-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mukund Keshao Gurjar. Retrieved from https://idiyas.com/inventor/mukund-keshao-gurjar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12

% Patents Active = 75.0

Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Hyderabad, IN (2001)
  • Maharashtra, IN (2002 - 2003)
  • Pune, IN (2001 - 2006)

Company Filing History:

goldMedal6 out of 2,130 
 
Council of Scientific and Industrial Research
 patents
silverMedal5 out of 855 
 
Millennium Pharmaceuticals Limited
 patents
bronzeMedal1 out of 36 
 
Millenium Pharmaceuticals, Inc.
 patents

Years Active: 2001-2006

Loading Chart...
12 patents (USPTO):Explore Patents
1. 7109353 - Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCl (2006-09-19),
2. 7041830 - Process for preparing (RS) 3-methyl-1-(2-piperidinyl phenyl) butyl amine (2006-05-09),
3. 6713639 - Process for preparing enantiomerically pure (S)-3-hydroxy-gamma-butyrolactone (2004-03-30),
4. 6566538 - Substituted oxygen alicyclic compounds, including methods for synthesis thereof (2003-05-20),
5. 6541647 - Methods of synthesis of substituted tetrahydrofuran compound (2003-04-01),
6. 6504044 - Process for the preparation of 1-[cyano(aryl)methyl] cyclohexanol (2003-01-07),
7. 6433197 - Substituted oxygen alicyclic compounds, including methods for synthesis thereof (2002-08-13),
8. 6403814 - Method for synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans (2002-06-11),
9. 6350912 - One pot process for the preparation of 1-[2-dimethylamino-(4-methoxyphenyl)-ethyl]cyclohexanol (2002-02-26),
10. 6310221 - Methods for synthesis of substituted tetrahydrofuran compound (2001-10-30),
11. 6306895 - Substituted oxygen alicyclic compounds, including methods for synthesis thereof (2001-10-23),
12. 6191279 - Dipyrano-quinolinones useful as anti viral agents and a process for preparing the same (2001-02-20),

Title: Mukund Keshao Gurjar: Innovator in Pharmaceutical Chemistry

Introduction

Mukund Keshao Gurjar is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 12 patents. His work primarily focuses on the development of processes for synthesizing important pharmaceutical compounds.

Latest Patents

Among his latest patents is a process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S)methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide hydrochloride, commonly known as Dorzolamide Hydrochloride. This compound is useful as an agent to reduce intraocular pressure by inhibiting the carbonic anhydrase enzyme. Another significant patent involves the preparation of (RS) 3-methyl-1-(2-piperidinyl phenyl) butyl amine, which serves as a key intermediate for the synthesis of repaglinide, an oral hypoglycemic agent.

Career Highlights

Throughout his career, Mukund has worked with esteemed organizations such as the Council of Scientific & Industrial Research and Millennium Pharmaceuticals Limited. His expertise in pharmaceutical processes has led to advancements in drug development and synthesis.

Collaborations

Mukund has collaborated with notable professionals in his field, including Mukund Shankar Chorghade and Sunil Vyankatesh Mhaskar. These collaborations have further enriched his contributions to pharmaceutical innovations.

Conclusion

Mukund Keshao Gurjar's work exemplifies the impact of innovation in pharmaceutical chemistry. His patents and collaborations highlight his commitment to advancing drug development and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…